<ѻý>Acamprosate Appears Safe for People With AUD and Liver Diseaseѻý> Phase II data suggest drug is well-tolerated and can reduce cravings in this group of patients Nov 09, 2022
<ѻý>BP Control Beneficial for Liver Transplant Recipientsѻý> Patients who kept their blood pressure under 140/90 mm Hg had better kidney function at 1 year Nov 07, 2022
<ѻý>Earlier Terlipressin May Be Better for HRS-AKI in Acute-on-Chronic Liver Failureѻý> More acute kidney injury reversals at 7 days and lower mortality with initiation at 12 hours Nov 07, 2022
<ѻý>Pandemic's Impact on Liver Disease in the Spotlight at Liver Meetingѻý> A roundup of news from the AASLD annual meeting Nov 04, 2022
<ѻý>New HRS Drug Cuts Need for Renal Replacement Tx After Liver Transplantѻý> Follow-up data from CONFIRM trial show terlipressin benefit in key subgroup Oct 25, 2022
<ѻý>New Standard-of-Care Therapy for Advanced Liver Cancerѻý> Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
<ѻý>FDA Approves New CTLA-4 Inhibitor for Cancer Treatmentѻý> Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
<ѻý>Bariatric Surgery in NAFLD Tied to Lower Heart Disease Riskѻý> In a large cohort, surgery associated with 49% lower risk of CVD versus nonsurgical care Oct 07, 2022
<ѻý>Noninvasive Gastric Mapping; Best Foods for the Gut? Lab Score for Crohn'sѻý> News and commentary from the world of gastroenterology and hepatology Sep 22, 2022
<ѻý>Obeticholic Acid Tied to Better Outcomes in Primary Biliary Cholangitisѻý> Study comparing randomized trial with two external cohorts showed fewer deaths, transplants Sep 22, 2022
<ѻý>FDA Finally OKs First Drug for Hepatorenal Syndromeѻý> Pivotal trial data showed terlipressin nearly doubled reversal of the condition Sep 15, 2022
<ѻý>Ryan Reynolds' Colonoscopy; NASH Drug Passes Phase II Test; New Drug Target in IBD?ѻý> News and commentary from the world of gastroenterology and hepatology Sep 14, 2022
<ѻý>More GI Docs, Fewer Alcoholic Liver Disease Deathsѻý> Study suggests access might account for 40% of alcohol-associated liver disease deaths nationally Aug 08, 2022
<ѻý>Adding TACE to Lenvatinib Boosts Survival in Advanced Liver Cancerѻý> In China-based trial, overall survival in first-line improved by 6 months versus lenvatinib alone Aug 04, 2022
<ѻý>Rare Mutations Linked to Protection Against Liver Diseaseѻý> Carriers of CIDEB variants were at lower risk for liver disease of any cause, study shows Jul 27, 2022
<ѻý>Novel Antifibrotic Improved Fibrosis in Chronic Hepatitis Bѻý> Phase II trial from China suggests benefit of add-on therapy Jul 15, 2022
<ѻý>Unexplained Acute Hepatitis in Children: More Evidence for Adenovirus 41ѻý> Two studies point to a suspiciously high prevalence Jul 13, 2022
<ѻý>Odevixibat Scratches the Itch of Kids' Rare Liver Diseaseѻý> Phase III trial showed reduced pruritus in progressive familial intrahepatic cholestasis Jul 08, 2022
<ѻý>Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screeningѻý> Hepatocellular carcinoma risk persisted after direct-acting antivirals Jun 30, 2022
<ѻý>EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2Dѻý> Noteworthy research from the European Association for the Study of the Liver annual meeting Jun 29, 2022
<ѻý>'A New Hope' for Rare, Deadly Liver Diseaseѻý> Small fazirsiran trial sees fibrosis regressions for liver disease associated with AAT deficiency Jun 28, 2022
<ѻý>Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosisѻý> Randomized trial showed improvements in cardiometabolic markers, but not liver fibrosis Jun 27, 2022
<ѻý>Liver Cirrhosis Tied to Elevated Risk for Strokeѻý> 37% higher risk observed in large German study Jun 25, 2022
<ѻý>Bulevirtide's Effect Sustained in Difficult-to-Treat Hepatitis Dѻý> Nearly half of patients at week 48 had virological and biochemical response Jun 25, 2022
<ѻý>Early Liver Disease Detection Linked to Subsequent Lifestyle Improvementsѻý> Danish study shows fibrosis screening associated with improved diet, alcohol use, and exercise Jun 24, 2022
<ѻý>Liver Preserved for 3 Days With Machine Perfusion Successfully Transplantedѻý> Patient healthy and leading normal life at 1 year Jun 01, 2022
<ѻý>POSE 2.0 Linked to Improved Outcomes in NAFLD Patients With Obesityѻý> Steatosis resolved in 53% of patients who underwent this minimally invasive procedure May 24, 2022
<ѻý>Medication for Drinking Addiction May Thwart Liver Diseaseѻý> Alcohol-related liver disease 63% lower for those taking medical addiction therapy May 20, 2022
<ѻý>MELD Scoring for Liver Transplants in Need of Sex Adjustment, Study Saysѻý> Researchers find "pervasive sex differences" in sodium-adjusted MELD scoring system May 18, 2022
<ѻý>Investigational Liver Drug Also Effective in Patients With Hypothyroidismѻý> "This is yet another reason endocrinologists should get involved in fatty liver disease" May 15, 2022
<ѻý>Fatigue Tied to Worse Outcomes in Patients With NASHѻý> Scores indicating worse fatigue associated with liver-related and decompensation events May 09, 2022
<ѻý>Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers?ѻý> News and commentary from the world of gastroenterology and hepatology Apr 28, 2022
<ѻý>PPIs Linked to Better Survival for One Group With Cirrhosisѻý> Large VA study shows potential benefit for one group, risk for the rest Apr 11, 2022
<ѻý>GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?ѻý> Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
<ѻý>In Cirrhosis, Less Activity Equals Worse Outcomesѻý> The lower the daily step count, the higher the risk of hospitalization and death Mar 23, 2022
<ѻý>Rinvoq Approved for UC; HCC Combo Flops; Disney Grants Pass to IBS Patientѻý> News and commentary from the world of gastroenterology and hepatology Mar 17, 2022
<ѻý>Robotic Hepatectomy Shows Benefits Over Laparoscopic Surgeryѻý> Shorter hospital stay, similar perioperative outcomes in matched analysis Mar 10, 2022
<ѻý>Kids With IBD Need Close Monitoring as They Grow Upѻý> Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
<ѻý>SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Dietѻý> News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
<ѻý>Recurrent Autoimmune Hepatitis Post-Liver Transplant: What Are the Risks?ѻý> Probability of recurrent disease more than doubled from 5 to 20 years later Feb 09, 2022